Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Update: Nasdaq Extends Weekly Winning Streak Amid Fed Pause Bets

Update: Nasdaq Extends Weekly Winning Streak Amid Fed Pause Bets

MT newswireMT newswire2026/10/02 20:52
By:MT newswire
04:52 PM EDT, 10/02/2026 (MT Newswires) -- (Updates with market moves at the end of the day, and other changes, if any.) The Nasdaq Composite rose Friday, securing its third weekly gain in a row, as weak jobs data signaled that the Federal Reserve could hold interest rates steady later this month. The index climbed 1.2% to 27,190.86. The S&P 500 added 0.7% to 7,722.72, while the Dow Jones Industrial Average advanced 0.5% to 51,176.96. Except healthcare, all sectors ended in the green, led by consumer discretionary. This week, the Nasdaq gained 0.5%, while the Dow and the S&P 500 logged weekly losses of 1.3% and 0.3%. Total nonfarm payrolls rose by 29,000 last month, the Bureau of Labor Statistics said Friday. That's just about a third of the 90,000 increase projected in a Bloomberg-compiled survey. The increase in August was adjusted downward by 29,000 to 133,000, while July's tally turned negative. "For the Fed, this number should be the nail in the coffin for an October hike," Jefferies Chief US Economist Thomas Simons said in a note e-mailed to MT Newswires. "We had been expecting that they would continue with successive 25 (basis-point) moves, but it now looks more likely that the policymakers emphasizing that they have some more time before another hike is needed will remain patient." Last month, the Federal Open Market Committee raised interest rates by 25 basis points, its first hike in just over three years, to combat inflation running persistently above its 2% target. The central bank's so-called "dot plot" signaled that a further rate increase could happen later this year. Markets are now pricing in a 77% probability that the FOMC will leave its benchmark lending rate unchanged toward the end of this month, up from 36% a week ago, according to the CME FedWatch tool. The odds in favor of a second consecutive 25-basis-point hike eased to 23% from 64%. Treasury yields were higher. The two-year rate rose 5.2 basis points to 4.84% and the 10-year rate added 4.7 basis points to 5.28%. Crude prices were mixed in Friday late-afternoon trade after the Group of Seven countries outlined plans to release 100 million barrels of oil and diesel products over a four-month period, citing "unprecedented" market volatility amid disruptions caused by the US-Iran war. West Texas Intermediate crude fell 1.4% to $91.54 a barrel, while Brent rose 0.5% to $102.86. Both benchmarks were down for the week, with WTI on track for its third consecutive weekly decline. In company news, Tesla's (TSLA) shares jumped 4.7% after the electric vehicle maker reported third-quarter deliveries above Wall Street's expectations. Ford Motor (F) fell 1.4% as its third-quarter US vehicle sales declined year over year. Nvidia (NVDA) gained 1.3%, among the best performers on the Dow. Morgan Stanley reinstated the chipmaker as its top pick in semiconductors. Nike (NKE) fell 3.6%, the biggest decline on the Dow. The sportswear giant forecast a fiscal 2027 revenue decline and unveiled a plan to transform its operating model, as Truist Securities warned that persistent business pressures are pushing back the company's turnaround timeline. Spot gold dropped 0.8% to $4,145.06 per troy ounce, while silver shed 0.7% to $60.78 per ounce.
2
1

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

"Predicting Your Prediction" Intensifies Tech Stock Sell-off! After $2.3 Trillion Market Value Evaporates, Has the "Hot Money" Mechanical Selling Still Not Subsided?

The Nasdaq 100 Index fell by 6.4%, wiping out $2.3 trillion in market capitalization. The core reason behind this decline is concerns that a comprehensive victory by the Democratic Party could lead to stricter regulations on AI development. Systematic funds, which typically follow the stock market's trend and respond to price fluctuations and momentum signals, were thus forced to reduce their investments, accelerating the downturn. The selling pressure from systematic strategies may not be over yet; it is expected that in the coming days, portfolios targeting volatility will sell at least $50 billion worth of stocks.

智通财经•2026/11/06 12:19

The midterm election tears open the "abyss" of AI trading, facing a moment of reckoning for trillion-dollar capital expenditure narratives

For months, investors have been worried about a series of risks behind the AI (artificial intelligence) capital expenditure "money tree." This week, the market finally pressed the panic selling button.

智通财经•2026/11/06 11:26
The midterm election tears open the "abyss" of AI trading, facing a moment of reckoning for trillion-dollar capital expenditure narratives